http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2008002316-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2008-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_134d0302d0b7f4e1efb98f7b5632c393 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2730eb4d055f672c506c6ca33137d3f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f79ecb3fd418c8d4db39e14999c578 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834cd90451ae0e63fff003d33c8ed5ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25052811a40d6b7a6b195b8de3cf746e |
| publicationDate | 2009-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CL-2008002316-A1 |
| titleOfInvention | Nitrogen heterocyclic compounds containing substituted phenylenediamine, inhibitors of the interaction between mdm2 and p53; preparation procedure; pharmaceutical composition; pharmaceutical combination; and use in the treatment of cancer. |
| abstract | A COMPOUND OF FORMULA (I), A FORM OF N-OXIDE, AN ADDITION SALT, A STEREOCHEMICALLY ISOMERIC FORM OR A SOLVATE OF THE SAME, OR ITS POLYMORPHIC FORM. USE OF SAID COMPOUND IN THE PREPARATION OF A USEFUL MEDICINE FOR THE TREATMENT OF A DISORDER MEDIATED BY AN INTERACTION BETWEEN P53-MDM2. <br /> A PHARMACEUTICAL COMPOSITION THAT INCLUDES ACCEPTABLE CARRIERS FOR PHARMACEUTICAL USE AND AS AN EFFECTIVE AMOUNT OF ACTIVE INGREDIENT SAID COMPOUND. A PHARMACEUTICAL COMBINATION THAT INCLUDES ONE OR MORE ANTI-CANCER AGENTS AND SAID COMPOUND. A PROCESS FOR PREPARING SUCH PHARMACEUTICAL COMPOSITION IN WHICH THE CARRIERS ACCEPTABLE FOR PHARMACEUTICAL USE AND SUCH COMPOUND ARE INTIMELY MIXED. <br /> |
| priorityDate | 2007-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947 |
Total number of triples: 21.